44.4 Million Estimated to Be Diagnosed With Cervical Cancer by 2069
From 2020 to 2069, 6.7 to 7.7 million cases could be averted by scaling up HPV vaccination by 2020
Odds of Receiving Tx for CAD Up With Medicare Advantage
However, no significant difference seen in intermediate outcomes for those enrolled in MA, FFS Medicare
Most Patients Do Not Disclose Complementary Medicine Use
Lack of inquiry from providers, fear of disapproval, belief CM is safe among reasons for nondisclosure
National Health Spending Set to Increase 5.5 Percent Annually
Long-observed demographic and economic factors expected to drive growth in health spending
Since Early 2000s, Overdose Death Rates Are Highest in U.S.
U.S. was not an outlier in terms of drug overdose mortality prior to the early 2000s
FDA: Gout Drug Uloric Increases Risk of Death
Medication is associated with increased risk of heart-related death and death from all causes
Vertical Integration Has Little Impact on Quality Measures
Increased hospital market concentration tied to reduced quality in patient satisfaction measures
Sacituzumab Govitecan Promising in Triple-Negative Breast Cancer
Response rate of 33.3 percent, median response duration of 7.7 months observed in 108 patients
Rivaroxaban Does Not Reduce VTE Incidence in High-Risk Cancer Patients
Primary end point occurred in lower percentage of patients in 180-day period; difference not significant
U.S. Agencies Probing Johnson & Johnson Over Asbestos in Talc
Company has faced lawsuits linking its body powders with ovarian cancer or mesothelioma
